Senangote, Leslie Ann .

HRN: 09-50-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2022
CEFUROXIME 500MG (TAB)
06/14/2022
06/20/2022
PO
500mg
BID
Thickly MSAF, UTI
Waiting Final Action 
06/14/2022
CO-AMOXICLAV 625MG (TAB)
06/14/2022
06/20/2022
PO
625mg
BID
Thickly MSAF, UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: